The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL

ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes

(2009) A. A. Margolin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo

(2008) L. C. Cerchietti et al.   BLOOD

BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells

(2008) Stella M. Ranuncolo et al.   BLOOD CELLS MOLECULES AND DISEASES

Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas

(2008) L. C. Cerchietti et al.   CANCER RESEARCH

BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent Manner

(2008) Stella Maris Ranuncolo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CtBP Is an Essential Corepressor for BCL6 Autoregulation

(2008) L. M. Mendez et al.   MOLECULAR AND CELLULAR BIOLOGY

IRF4 addiction in multiple myeloma

(2008) Arthur L. Shaffer et al.   NATURE

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

(2008) G. Lenz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA